Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P S Mitrou

Showing results (61-70 of 104) with videos related to

Pageof 11
Sort By:
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|April 17, 1977
[2 cases of necrotizing angiitis]J Meier-Sydow, P S Mitrou, E Vorbach, et al.
Onkologie|June 1, 1986
Age adapted induction and intensified consolidation therapy in acute myelogenous leukemiaE Kurrle, G Ehninger, M Freund, et al.
Scandinavian Journal of Haematology|September 1, 1982
Expression of Ia-like antigen in lymphatic leukaemias and non-hodgkin lymphomas in correlation with other surface markersL Bergmann, P S Mitrou, T Cherdron, et al.
Cancer|September 1, 1993
Daily alternating administration of high-dose alpha-2b-interferon and interleukin-2 bolus infusion in metastatic renal cell cancer. A phase II studyL Bergmann, K Fenchel, E Weidmann, et al.
HNO|February 1, 1987
[Chemotherapy or chemotherapy and radiotherapy in advanced head and neck tumors. A prospective, randomized study comparing the 2 therapeutic modalities]A Klima, C von Ilberg, L Bergmann, et al.
Respiration; International Review of Thoracic Diseases|January 1, 1985
Prognostic value of chest radiograph, serum-angiotensin-converting enzyme and T helper cell count in blood and in bronchoalveolar lavage of patients with pulmonary sarcoidosisM Rust, L Bergmann, T Kühn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 16, 2002
Bendamustine is effective in relapsed or refractory aggressive non-Hodgkin's lymphomaE Weidmann, S-Z Kim, A Rost, et al.
Leukemia & Lymphoma|May 9, 2001
Changing incidence and survival in patients with aids-related non-Hodgkin's lymphomas in the era of highly active antiretroviral therapy (HAART)K U Chow, P S Mitrou, K Geduldig, et al.
Onkologie|December 1, 1983
[Results of drug therapy of inoperable non-small cell lung carcinoma with VP 16-213 (Etoposide) and cis-platin. A phase II study]T Klippstein, M Graubner, W E Berdel, et al.
Haematologica|June 19, 2001
In vitro induction of apoptosis of neoplastic cells in low-grade non-Hodgkin's lymphomas using combinations of established cytotoxic drugs with bendamustineK U Chow, S Boehrer, K Geduldig, et al.
Pageof 11

Showing results (61-70 of 104) with videos related to

Sort By:
Pageof 11
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|April 17, 1977
[2 cases of necrotizing angiitis]J Meier-Sydow, P S Mitrou, E Vorbach, et al.
Onkologie|June 1, 1986
Age adapted induction and intensified consolidation therapy in acute myelogenous leukemiaE Kurrle, G Ehninger, M Freund, et al.
Scandinavian Journal of Haematology|September 1, 1982
Expression of Ia-like antigen in lymphatic leukaemias and non-hodgkin lymphomas in correlation with other surface markersL Bergmann, P S Mitrou, T Cherdron, et al.
Cancer|September 1, 1993
Daily alternating administration of high-dose alpha-2b-interferon and interleukin-2 bolus infusion in metastatic renal cell cancer. A phase II studyL Bergmann, K Fenchel, E Weidmann, et al.
HNO|February 1, 1987
[Chemotherapy or chemotherapy and radiotherapy in advanced head and neck tumors. A prospective, randomized study comparing the 2 therapeutic modalities]A Klima, C von Ilberg, L Bergmann, et al.
Respiration; International Review of Thoracic Diseases|January 1, 1985
Prognostic value of chest radiograph, serum-angiotensin-converting enzyme and T helper cell count in blood and in bronchoalveolar lavage of patients with pulmonary sarcoidosisM Rust, L Bergmann, T Kühn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 16, 2002
Bendamustine is effective in relapsed or refractory aggressive non-Hodgkin's lymphomaE Weidmann, S-Z Kim, A Rost, et al.
Leukemia & Lymphoma|May 9, 2001
Changing incidence and survival in patients with aids-related non-Hodgkin's lymphomas in the era of highly active antiretroviral therapy (HAART)K U Chow, P S Mitrou, K Geduldig, et al.
Onkologie|December 1, 1983
[Results of drug therapy of inoperable non-small cell lung carcinoma with VP 16-213 (Etoposide) and cis-platin. A phase II study]T Klippstein, M Graubner, W E Berdel, et al.
Haematologica|June 19, 2001
In vitro induction of apoptosis of neoplastic cells in low-grade non-Hodgkin's lymphomas using combinations of established cytotoxic drugs with bendamustineK U Chow, S Boehrer, K Geduldig, et al.
Pageof 11